Browse > Article
http://dx.doi.org/10.7314/APJCP.2015.16.3.933

Prognostic Significance of Preoperative Anemia, Leukocytosis and Thrombocytosis in Chinese Women with Epithelial Ovarian Cancer  

Chen, Ying (Department of Gynecologic Oncology, Tianjin Medical University Cancer Institute and Hospital)
Zhang, Lei (Department of Gynecologic Oncology, Tianjin Medical University Cancer Institute and Hospital)
Liu, Wen-Xin (Department of Gynecologic Oncology, Tianjin Medical University Cancer Institute and Hospital)
Liu, Xiang-Yu (Department of Gynecologic Oncology, Tianjin Medical University Cancer Institute and Hospital)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.16, no.3, 2015 , pp. 933-939 More about this Journal
Abstract
Malignant tumors are often accompanied by increased risk of hematological abnormalities. However, few studies have reported any prognostic impact of preoperative thrombocytosis, leukocytosis and anemia in epithelia ovarian cancer (EOC). This study aimed to investigate preoperative hematological parameters for anemia, leukocytosis and thombocytosis in relation to established prognostic factors and survival in EOC cases. A total of 816 Chinese women treated for EOC were retrospectively included in the study focusing on the relationship between preoperative hemoglobin, leukocyte and platelet counts, and a panel of clinicopathologic characteristics and outcome. Preoperative anemia was present in 13.4%, leukocytosis in 16.7% and thrombocytosis in 22.8%. Additionally, EOC patients with low differentiation grade, advanced stage, lymph node (LN) metastasis, residual disease ${\geq}1cm$, ascites volume >1,000ml, serum cancer antigen 125 (CA125) >675U/ml, and disease recurrence had the higher prevalence of preoperative anemia, leukocytosis and thrombocytosis (all p<0.05). Moreover, EOC patients with older age or postmenopausal EOC patients had the higher prevalence of thrombocytosis (28.7% vs 17.3% or 26.0% vs 17.7%). Furthermore, in a Cox proportional hazard model, thrombocytosis was an independent factor for progression-free survival (PFS) and overall survival (OS) (p<0.001). Conclusively, preoperative anemia, leukocytosis or thrombocytosis in EOC patients is closely associated with more malignant disease phenotype and poorer prognosis. Significantly, thrombocytosis may independently predict the disease-specific survival for EOC patients.
Keywords
Epithelial ovarian cancer; anemia; leukocytosis; thrombocytosis; prognosis;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Acs G, Xu X, Chu C, Acs P, Verma A (2004). Prognostic significance of erythropoietin expression in human endometrial carcinoma. Cancer, 100, 2376-86.   DOI
2 Akl EA, van Doormaal FF, Barba M, et al (2007). Parenteral anticoagulation for prolonging survival in patients with cancer who have no other indication for anticoagulation. Cochrane Database Syst Rev, 18, CD006652.
3 Antonioli L, Blandizzi C, Pacher P, Hasko G (2013) Immunity, inflammation and cancer: a leading role for adenosine. Nat Rev Cancer, 13, 842-57.   DOI
4 Ashour AA, Verschraegen CF, Kudelka AP, Kavanagh JJ (1997). Paraneoplastic syndromes of gynecologic neoplasms. J Clin Oncol, 15, 1272-82.
5 Burger RA (2011). Overview of anti-angiogenic agents in development for ovarian cancer. Gynecol Oncol, 121, 230-8.   DOI
6 Cao Y, Liu Q (2007). Therapeutic targets of multiple angiogenic factors for the treatment of cancer and metastasis. Adv Cancer Res, 97, 203-24.   DOI
7 Cho MS, Bottsford-Miller J, Vasquez HG, et al (2012). Platelets increase the proliferation of ovarian cancer cells. Blood, 120, 4869-72.   DOI   ScienceOn
8 Cordella C, Luebbers HT, Rivelli V, Gratz KW, Kruse AL (2011). An evaluation of the preoperative hemoglobin level as a prognostic factor for oral squamous cell carcinoma. Head Neck Oncol, 3, 35.   DOI
9 Cullis J. (2013). Anaemia of chronic disease. Clin Med, 13, 193-6.
10 Dicato M, Plawny L, Diederich M (2010). Anemia in cancer. Ann Oncol, 21, 167-72.
11 Gastl G, Plante M, Finstad CL, et al (1993). High IL-6 levels in ascitic fluid correlate with reactive thrombocytosis in patients with epithelial ovarian cancer. Br J Haematol, 83, 433-41.   DOI
12 Gavalas NG, Liontos M, Trachana SP, et al (2013). Angiogenesisrelated pathways in the pathogenesis of ovarian cancer. Int J Mol Sci, 14, 15885-909.   DOI
13 Gerestein CG, Eijkemans MJ, de Jong D, et al (2009). The prediction of progression-free and overall survival in women with an advanced stage of epithelial ovarian carcinoma. BJOG, 116, 372-80.   DOI
14 Grivennikov SI, Greten FR, Karin M (2010). Immunity, inflammation, and cancer. Cell, 140, 883-99.   DOI
15 Gungor T, Kanat-Pektas M, Sucak A, Mollamahmutoglu L (2009). The role of thrombocytosis in prognostic evaluation of epithelial ovarian tumors. Arch Gynecol Obstet, 279, 53-6.   DOI
16 Hanahan D, Weinberg RA (2011). Hallmarks of cancer: the next generation. Cell, 144, 646-74.   DOI
17 Hardee ME, Arcasoy MO, Blackwell KL, Kirkpatrick JP, Dewhirst MW (2006). Erythropoietin biology in cancer. Clin Cancer Res, 12, 332-9.   DOI
18 Jung MR, Park YK, Jeong O, et al (2011). Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stage gastric cancer. J Surg Oncol, 104, 504-10.   DOI   ScienceOn
19 Herzog TJ, Vermorken JB, Pujade-Lauraine E, et al (2011). Correlation between CA-125 serum level and response by RECIST in a phase III recurrent ovarian cancer study. Gynecol Oncol, 122, 350-5.   DOI
20 Holgersson G, Sandelin M, Hoye E, et al (2012). Swedish lung cancer radiation study group: the prognostic value of anaemia, thrombocytosis and leukocytosis at time of diagnosis in patients with non-small cell lung cancer. Med Oncol, 29, 3176-82.   DOI
21 Khorana AA (2009). Cancer and thrombosis: implications of published guidelines for clinical practice. Ann Oncol, 20, 1619-30.   DOI   ScienceOn
22 Li FX, Wei LJ, Zhang H, Li SX, Liu JT (2014). Significance of thrombocytosis in clinicopathologic characteristics and prognosis of gastric cancer. Asian Pac J Cancer Prev, 15, 6511-7.   DOI
23 Mabuchi S, Matsumoto Y, Isohashi F, et al (2011). Pretreatment leukocytosis is an indicator of poor prognosis in patients with cervical cancer. Gynecol Oncol, 122, 25-32.   DOI
24 Mroczko B, Groblewska M, Wereszczynska-Siemiatkowska U, et al (2007). Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis. Clin Chim Acta, 380, 208-12.   DOI
25 Njolstad TS, Engerud H, Werner HM, Salvesen HB, Trovik J (2013). Preoperative anemia, leukocytosis and thrombocytosis identify aggressive endometrial carcinomas. Gynecol Oncol, 131, 410-5.   DOI
26 Pelosof LC, Gerber DE (2010). Paraneoplastic syndromes: an approach to diagnosis and treatment. Mayo Clin Proc, 85, 838-54.   DOI
27 Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin, 63, 11-30.   DOI   ScienceOn
28 Qiu MZ, Xu RH, Ruan DY, et al (2010). Incidence of anemia, leukocytosis, and thrombocytosis in patients with solid tumors in China. Tumour Biol, 31, 633-41.   DOI
29 Qiu MZ, Yuan ZY, Luo HY, et al. (2010). Impact of pretreatment hematologic profile on survival of colorectal cancer patients. Tumour Biol, 31, 255-60.   DOI
30 Seo KH, Lee HS, Jung B, et al (2004). Estrogen enhances angiogenesis through a pathway involving platelet-activating factor-mediated nuclear factor-kappaB activation. Cancer Res, 64, 6482-8.   DOI
31 Stone RL, Nick AM, McNeish IA, et al (2012). Paraneoplastic thrombocytosis in ovarian cancer. N Engl J Med, 366, 610-8.   DOI
32 Tomita M, Shimizu T, Hara M, Ayabe T, Onitsuka T (2008). Impact of preoperative hemoglobin level on survival of nonsmall cell lung cancer patients. Anticancer Res, 28, 1947-50.
33 Unal D, Eroglu C, Kurtul N, Oguz A, Tasdemir A (2013). Are neutrophil/lymphocyte and platelet/lymphocyte rates in patients with non-small cell lung cancer associated with treatment response and prognosis? Asian Pac J Cancer Prev, 14, 5237-42.   DOI   ScienceOn
34 van Rossum AP, Vlasveld LT, Vlasveld IN, et al (2009) Granulocytosis and thrombocytosis in renal cell carcinoma: a pro-inflammatory cytokine response originating in the tumour. Neth J Med, 67, 191-4.
35 Weiss G, Goodnough LT (2005). Anemia of chronic disease. N Engl J Med, 352, 1011-23.   DOI
36 Wheler J, Tsimberidou AM, Hong D, et al (2009). Survival of patients in a phase 1 clinic: the M.D. Anderson Cancer Center experience. Cancer, 115, 1091-9.   DOI
37 Yasuda Y, Fujita Y, Masuda S, et al (2002). Erythropoietin is involved in growth and angiogenesis in malignant tumours of female reproductive organs. Carcinogenesis, 23, 1797-805.   DOI